LINC01411

Summary

LINC01411 (long intergenic non-protein coding RNA 1411, HGNC:50703) is a long non-coding RNA gene on chromosome 5q35.2.

At a glance

• Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:50703
Approved symbol	LINC01411
Name	long intergenic non-protein coding RNA 1411
Location	5q35.2
Locus type	RNA, long non-coding
Status	Approved
Aliases	RP11-267A15.1
Ensembl gene	ENSG00000249306
Ensembl biotype	lncRNA
Entrez	101928176
RNAcentral	URS00007E506F — lncRNA, 1095 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 20 — 20 lncRNA

ENST00000504512, ENST00000506862, ENST00000507361, ENST00000510234, ENST00000511707, ENST00000515513, ENST00000664184, ENST00000685618, ENST00000687783, ENST00000757676, ENST00000757677, ENST00000757678, ENST00000757679, ENST00000757680, ENST00000757681, ENST00000757682, ENST00000757683, ENST00000757684, ENST00000757685, ENST00000757686

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000504512 — 7 exons

Exon	Start	End
ENSE00002064392	174526228	174526448
ENSE00002068933	174524062	174524161
ENSE00004109012	174532035	174532445
ENSE00004109037	174528367	174528539
ENSE00004109038	174531330	174531403
ENSE00004109044	174526864	174527045
ENSE00004109045	174503683	174503990

Expression profiles

Bgee: expression breadth ubiquitous, 106 present calls, max score 80.30.

FANTOM5 (CAGE): breadth broad, TPM avg 1.4893 / max 49.7464, expressed in 246 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter ID	TPM avg	Samples expressed
60329	0.6410	140
60334	0.3325	76
60327	0.1504	69
60328	0.1249	64
60336	0.0993	57
60335	0.0906	55
60330	0.0507	36

Top tissues by expression

109 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
corpus callosum	UBERON:0002336	80.30	gold quality
right frontal lobe	UBERON:0002810	78.56	gold quality
substantia nigra	UBERON:0002038	78.44	gold quality
Brodmann (1909) area 9	UBERON:0013540	78.33	gold quality
male germ line stem cell (sensu Vertebrata) in testis	CL:0000089 ∩ UBERON:0000473	78.30	silver quality
Ammon’s horn	UBERON:0001954	78.18	gold quality
amygdala	UBERON:0001876	77.62	gold quality
temporal lobe	UBERON:0001871	77.56	gold quality
C1 segment of cervical spinal cord	UBERON:0006469	76.99	gold quality
spinal cord	UBERON:0002240	76.93	gold quality
dorsolateral prefrontal cortex	UBERON:0009834	76.30	gold quality
anterior cingulate cortex	UBERON:0009835	76.30	gold quality
cerebral cortex	UBERON:0000956	75.80	gold quality
frontal cortex	UBERON:0001870	74.44	gold quality
primary visual cortex	UBERON:0002436	74.36	gold quality
putamen	UBERON:0001874	73.83	gold quality
brain	UBERON:0000955	73.75	gold quality
superior frontal gyrus	UBERON:0002661	73.14	gold quality
right hemisphere of cerebellum	UBERON:0014890	72.55	gold quality
hypothalamus	UBERON:0001898	72.49	gold quality
cerebellar vermis	UBERON:0004720	71.73	gold quality
prefrontal cortex	UBERON:0000451	71.63	gold quality
cerebellum	UBERON:0002037	71.62	gold quality
caudate nucleus	UBERON:0001873	71.53	gold quality
cerebellar cortex	UBERON:0002129	71.53	gold quality
cerebellar hemisphere	UBERON:0002245	71.39	gold quality
nucleus accumbens	UBERON:0001882	70.25	gold quality
ascending aorta	UBERON:0001496	68.05	gold quality
thoracic aorta	UBERON:0001515	67.86	gold quality
descending thoracic aorta	UBERON:0002345	67.83	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	3.58

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.